These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21054687)

  • 1. Differential response to IV carfentanil in chronic cocaine users and healthy controls.
    Minkowski CP; Epstein D; Frost JJ; Gorelick DA
    Addict Biol; 2012 Jan; 17(1):149-55. PubMed ID: 21054687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients.
    Ghitza UE; Preston KL; Epstein DH; Kuwabara H; Endres CJ; Bencherif B; Boyd SJ; Copersino ML; Frost JJ; Gorelick DA
    Biol Psychiatry; 2010 Oct; 68(8):697-703. PubMed ID: 20579973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino ML; Dannals RF; Frost JJ
    Psychopharmacology (Berl); 2008 Nov; 200(4):475-86. PubMed ID: 18762918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving.
    Zubieta JK; Gorelick DA; Stauffer R; Ravert HT; Dannals RF; Frost JJ
    Nat Med; 1996 Nov; 2(11):1225-9. PubMed ID: 8898749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute acetate administration increases endogenous opioid levels in the human brain: A [
    Ashok AH; Myers J; Frost G; Turton S; Gunn RN; Passchier J; Colasanti A; Marques TR; Nutt D; Lingford-Hughes A; Howes OD; Rabiner EA
    J Psychopharmacol; 2021 May; 35(5):606-610. PubMed ID: 33406950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
    Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
    Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amphetamine on the human brain opioid system--a positron emission tomography study.
    Guterstam J; Jayaram-Lindström N; Cervenka S; Frost JJ; Farde L; Halldin C; Franck J
    Int J Neuropsychopharmacol; 2013 May; 16(4):763-9. PubMed ID: 22932428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced mu opioid receptor availability in schizophrenia revealed with [
    Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD
    Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of [
    Kelleher AC; Pearson TD; Ramsey J; Zhao W; O'Conor KA; Bakhoda A; Stodden T; Guo M; Eisenberg SM; Shah SV; Freaney ML; Kim W; Kang Y; Tomasi D; Johnson C; Fang CA; Volkow ND; Kim SW
    Sci Rep; 2024 Jul; 14(1):16250. PubMed ID: 39009645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.
    Mick I; Myers J; Ramos AC; Stokes PR; Erritzoe D; Colasanti A; Gunn RN; Rabiner EA; Searle GE; Waldman AD; Parkin MC; Brailsford AD; Galduróz JC; Bowden-Jones H; Clark L; Nutt DJ; Lingford-Hughes AR
    Neuropsychopharmacology; 2016 Jun; 41(7):1742-50. PubMed ID: 26552847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.
    Johansson J; Hirvonen J; Lovró Z; Ekblad L; Kaasinen V; Rajasilta O; Helin S; Tuisku J; Sirén S; Pennanen M; Agrawal A; Crystal R; Vainio PJ; Alho H; Scheinin M
    Neuropsychopharmacology; 2019 Aug; 44(9):1667-1673. PubMed ID: 30867551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
    Nuechterlein EB; Ni L; Domino EF; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interindividual variability and lateralization of μ-opioid receptors in the human brain.
    Kantonen T; Karjalainen T; Isojärvi J; Nuutila P; Tuisku J; Rinne J; Hietala J; Kaasinen V; Kalliokoski K; Scheinin H; Hirvonen J; Vehtari A; Nummenmaa L
    Neuroimage; 2020 Aug; 217():116922. PubMed ID: 32407992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain.
    Joutsa J; Karlsson HK; Majuri J; Nuutila P; Helin S; Kaasinen V; Nummenmaa L
    Psychiatry Res Neuroimaging; 2018 Jun; 276():41-45. PubMed ID: 29655552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.
    Majuri J; Joutsa J; Johansson J; Voon V; Alakurtti K; Parkkola R; Lahti T; Alho H; Hirvonen J; Arponen E; Forsback S; Kaasinen V
    Neuropsychopharmacology; 2017 Apr; 42(5):1169-1177. PubMed ID: 27882998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional brain [(11)C]carfentanil binding following tobacco smoking.
    Domino EF; Hirasawa-Fujita M; Ni L; Guthrie SK; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():100-104. PubMed ID: 25598501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.
    Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J
    Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.
    Karjalainen T; Tuominen L; Manninen S; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L
    Soc Cogn Affect Neurosci; 2016 Aug; 11(8):1310-6. PubMed ID: 27053768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.
    Turton S; Myers JF; Mick I; Colasanti A; Venkataraman A; Durant C; Waldman A; Brailsford A; Parkin MC; Dawe G; Rabiner EA; Gunn RN; Lightman SL; Nutt DJ; Lingford-Hughes A
    Mol Psychiatry; 2020 Aug; 25(8):1749-1758. PubMed ID: 29942043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.